Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Mutat Res ; 401(1-2): 193-7, 1998 Jun 05.
Article in English | MEDLINE | ID: mdl-9639704

ABSTRACT

As a result of the activities of the first Soviet plutonium production reactor, large territories of the Southern Urals were exposed to radioactive contamination. Three different incidents occurring between 1948 and 1967 lead to major exposure. A total of 280,000 people residing on the contaminated territories were exposed both to external and internal contamination particularly due to the long-lived radionuclides 137Cs and 90Sr. The highest doses were received by 28,000 people living on the Techa riverside villages. In the present paper 15 presumably exposed children coming from the Muslyumovo village on the Techa river have been analyzed using conventional cytogenetic procedure in order to assess a radiation-induced damage. The data obtained have been compared to a group of matched unexposed controls. The results show a statistical difference between the two cohorts which suggests a possible residual contamination representing a continuous hazard for the new generations.


Subject(s)
Blood Cells/radiation effects , Chromosome Aberrations , Nuclear Reactors , Radioactive Hazard Release , Cesium Radioisotopes , Child , Cohort Studies , Environmental Pollution , Female , Humans , Male , Metaphase , Russia , Strontium , USSR
2.
Mutat Res ; 395(2-3): 249-54, 1997 Dec 12.
Article in English | MEDLINE | ID: mdl-9465937

ABSTRACT

In a previous paper we reported that a group of children exposed to ionizing radiation following the Chernobyl accident exhibited an appreciable number of chromosome breaks and rearrangements reflecting the persistence of a radiation-induced damage. The results suggested that the children were still exposed to radioactive contamination through consumer foodstuff and life styles. In the present paper, 31 exposed children have been considered together with a control group of 11 children with the aim to confirm previous results. All children underwent whole-body counter (WBC) measures and conventional cytogenetic analysis. The frequency of chromosome aberrations detected by conventional cytogenetics in the group of children chronically exposed to low doses of ionizing radiation resulted in significant differences with respect to the control group. The present work suggests that, for these groups of children, even if the frequency of aberrations is very low and the observation of statistically significant differences is consequently a problem, a persistently abnormal cytogenetic picture is still present several years after the accident.


Subject(s)
Chromosome Aberrations , Lymphocytes/radiation effects , Radioactive Hazard Release , Child , Female , Humans , Male , Nuclear Reactors , Power Plants , Radiation Dosage , Republic of Belarus , Ukraine
3.
Mutat Res ; 332(1-2): 33-8, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7500989

ABSTRACT

Several studies suggest that cells appear to become less susceptible to the induction of radiation damage, and in particular of chromosome and chromatid aberrations in short-term cultures of human lymphocytes, when a challenge exposure to ionizing radiation is preceded by a low 'adaptive' dose. Contradictory results have been reported on the conditions under which the phenomenon can be evidenced. In the present work, circulating lymphocytes of 13 children contaminated from the fallout after the Chernobyl accident were tested for their capability to exhibit an adaptive response in experiments in which the challenge dose was administered to stimulated lymphocytes in the S-G2 phase. Furthermore, the possible influence of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) polymerase, was also investigated. Our results indicate that, at least in the instance of the end-point here used (chromosome and chromatid aberrations, the former resulting possibly from the Cs burden), human lymphocytes, chronically exposed to low doses from fallout, do not exhibit any decreased susceptibility to ionizing radiation. However, as reported in the accompanying paper, the same samples appear to show an 'adaptive' response when exposed to a challenge treatment with bleomycin (B. Tedeschi et al., 1995, this issue).


Subject(s)
Benzamides/pharmacology , Chromosome Aberrations , Lymphocytes/radiation effects , Radiation-Sensitizing Agents/pharmacology , Radioactive Hazard Release , Sister Chromatid Exchange/radiation effects , Adaptation, Physiological , Cell Cycle/drug effects , Cell Cycle/radiation effects , Cells, Cultured , Child , Female , Humans , Lymphocytes/drug effects , Lymphocytes/ultrastructure , Male , Radiation Dosage , Sister Chromatid Exchange/drug effects , Ukraine
4.
Mutat Res ; 332(1-2): 39-44, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7500990

ABSTRACT

The present study concerns the possible adaptive response, induced in vivo by a continuous exposure to ionizing radiations, to a challenge treatment with the radiomimetic glycopeptide bleomycin (BLM). Lymphocytes from children contaminated as a consequence of Chernobyl accident were treated for the last 5 h of culture with 2.5 micrograms/ml BLM. The induced chromosome damage was significantly lower than that found with the same treatment in lymphocytes from control children. This hyposensitivity to BLM was still present if, 1 h after the addition of the drug, inhibitors of the enzymes involved in DNA repair, such as 3-aminobenzamide (2 mM), or aphidicolin (0.4 microM) or 3-dideoxythymidine (5 mM) were added to the cultures. The resistance to BLM in lymphocytes from contaminated children seems to be related to a mechanism upstream in respect to the activities of enzymes involved in the DNA repair and specifically linked to the action of this drug. This is consistent with the different response found when the cells were challenged with ionizing radiation in vitro, as reported in the accompanying paper (L. Padovani, L. et al. (1995) Mutation Res., this issue).


Subject(s)
Antimetabolites, Antineoplastic/pharmacology , Bleomycin/pharmacology , Chromosome Aberrations , DNA Damage/drug effects , DNA Repair/drug effects , Lymphocytes/drug effects , Radioactive Hazard Release , Adaptation, Physiological/drug effects , Cells, Cultured , Child , DNA Damage/radiation effects , Female , Humans , Lymphocytes/radiation effects , Male , Ukraine
SELECTION OF CITATIONS
SEARCH DETAIL
...